An observational study in Infective Endocarditis, sponsored by Centre Hospitalier Universitaire de Besancon. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-27.
Sponsored by Centre Hospitalier Universitaire de Besancon · Observational
Infective endocarditis (IE) is a rare (30 cases / million / year in France) and serious (20 % of deaths during hospitalization) disease . Its epidemiological profile was considerably modified these last years.New predisposing factors appeared, due to increasing number of patients wearing valvular prosthetics. The purpose of this study is to realize in 2008 a new observational study on populational basis to describe and analyze the evolution of the epidemiology of IE in France, compared to previous studies conducted in 1991 and 1999.
It is a prospective observational study based on a population of 25 million inhabitants. The cases are recruited over a one year period, from January 1st till December 31st, 2008, in six regions of France (Rhône-Alpes, Paris et Petite Couronne, Lorraine, Franche-Comté, Marne, Languedoc-Roussillon) and in the department of Ille-et-Vilaine. The IE cases are declared by clinicians taking care of the patients, microbiologists and cardiac ultrasonographists.
173 studies on the registry are indexed under Endocarditis; 57 are open to participants now.
This study's enrollment of 484 is above the median of 225 across 82 observational studies indexed under Endocarditis.
Browse Endocarditis studies →Centre Hospitalier Universitaire de Besancon is the lead sponsor of 450 studies on the registry; 97 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inpatients with infective endocarditis living in one of the studied regions
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The application of diagnostic classification criteria of Duke modified by Li is carried out after collection of all the data at the output of the patient. Will be included in the observatory that patients meeting criteria for definite or possible endocarditis.
Exclusion Criteria:
Mortality
Vital status
Time frame: 1 year
Frequency of antibiotic resistance by the germs (streptococci and staphylococci)
antibiotic treatments and outcome
Time frame: during the hospitalization, 1 year maximum
No study locations are listed for this record.
Plan to share: No
Ran from Dec 2007 to primary completion in Dec 2009, 24 months.
Of 36 observational studies under Endocarditis, half reached primary completion within 62 months of starting (the median), counting those still running; a quarter within 36. This study's 24 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Besancon →